NASDAQ:ICCC

Immucell Stock News

Healthcare > Biotechnology

Buy ICCC

*Your capital is at risk

$10.05

+0.260 (+2.66%)

At Close: Jun 03, 2026

ImmuCell: FDA Catalyst Could Unlock 60+% Upside

12:00am, Friday, 24'th Aug 2018

ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2018 Results - Earnings Call Transcript

12:00am, Tuesday, 14'th Aug 2018

ImmuCell Q2 EPS $(0.15) Down From $(0.05) YoY, Sales $3M Up From $1.75M YoY

12:00am, Monday, 13'th Aug 2018

ImmuCell Announces Sale of Certain Non-Core Assets For $700K

12:00am, Wednesday, 25'th Jul 2018

ImmuCell Sees Q2 Product Sales $3M Up From $1.8M YoY

12:00am, Tuesday, 10'th Jul 2018

Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway

12:00am, Tuesday, 15'th May 2018

ImmuCell's (ICCC) CEO Michael Brigham on Q1 2018 Results - Earnings Call Transcript

12:00am, Monday, 14'th May 2018

ImmuCell's (ICCC) CEO Michael Brigham on Q4 2017 Results - Earnings Call Transcript

12:00am, Friday, 09'th Feb 2018

ImmuCell Reports Prelim. Q4 EPS $(0.04) vs $0.01 In Same Qtr. Last Year, Total Product Sales ~$919K

12:00am, Thursday, 08'th Feb 2018

ImmuCell to Announce Financial Results for Fourth Quarter and Full Year —…–7

12:00am, Monday, 05'th Feb 2018

ImmuCell Corporation Announces Closing of $' Million Public Offering of Common Stock

12:00am, Thursday, 21'st Dec 2017

45 Biggest Movers From Yesterday

12:00am, Wednesday, 20'th Dec 2017

ImmuCell Prices its $3M Offering at $7.30/Share

12:00am, Tuesday, 19'th Dec 2017

Immucell Stock News

ImmuCell: FDA Catalyst Could Unlock 60+% Upside

ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2018 Results - Earnings Call Transcript

ImmuCell Q2 EPS $(0.15) Down From $(0.05) YoY, Sales $3M Up From $1.75M YoY

ImmuCell Announces Sale of Certain Non-Core Assets For $700K

ImmuCell Sees Q2 Product Sales $3M Up From $1.8M YoY

Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway

ImmuCell's (ICCC) CEO Michael Brigham on Q1 2018 Results - Earnings Call Transcript

ImmuCell's (ICCC) CEO Michael Brigham on Q4 2017 Results - Earnings Call Transcript

ImmuCell Reports Prelim. Q4 EPS $(0.04) vs $0.01 In Same Qtr. Last Year, Total Product Sales ~$919K

ImmuCell to Announce Financial Results for Fourth Quarter and Full Year —…–7

ImmuCell Corporation Announces Closing of $' Million Public Offering of Common Stock

45 Biggest Movers From Yesterday

ImmuCell Prices its $3M Offering at $7.30/Share

ImmuCell Reports Q3 EPS $(0.07) vs. $0.01 In Same Qtr. Last Year, Sales $2M vs. $2M YoY

ImmuCell to Announce Financial Results for Third Quarter of —…–7

Top Fintech Company